Weight Loss Telehealth in Illinois 2026 15 Providers Compared, Ranked, and Priced

Illinois residents have access to 15 legitimate weight loss telehealth providers in 2026. That is one of the larger selections in the country, which gives you real options across price points, medication types, and care models. Before you spend time comparing plans, though, know that Clinic Secret, Nurx, and UrWay Health do not operate in Illinois. If you have seen those names recommended somewhere and tried to sign up, that is why it did not work.

The 15 providers available to you are: Ro, Medvi, MyStart Health, Strut, Sprout Health, Eden, Peter MD, Skinny.Rx, Hers, Hims, Shed, PlushCare, Sesame Care, Henry Meds, and Ivim Health. That list covers every major category: compounded GLP-1 specialists, brand-name insurance navigation platforms, budget-first options, and platforms that bundle behavioral coaching with medication. Your job is not to find a provider that works in Illinois, it is to find the right one for your situation.

The ratings across Illinois-available providers are tightly clustered, which tells you something. Strut and Hims both sit at 9.0/10. Medvi and Ro are both at 8.9/10. The spread from the top-rated to the lowest-rated (Ivim Health at 8.0) is less than a full point. Differences in what you actually experience will come down to medication type, pricing model, and whether you have insurance, not raw review scores.

Illinois sits in a favorable regulatory position for weight loss telehealth compared to many other states. The state has full insurance parity, meaning your telehealth weight loss consultation is reimbursed at the same rate as an in-person visit with a doctor. That matters if you have commercial insurance and want to use it. It does not apply to Medicaid, where weight loss medications are generally not a covered benefit regardless of how you access care.

Compounded semaglutide and compounded tirzepatide are legally available to Illinois residents through licensed 503B outsourcing pharmacies. The FDA allowed this while Wegovy and Zepbound were in shortage; those shortages were declared resolved in December 2024 and February 2025. In Illinois, the practical result is that most telehealth platforms offering compounded GLP-1s are working with 503B-compliant pharmacies, which are held to stricter manufacturing standards than individual compounding pharmacies. When you see a provider advertising compounded semaglutide at $149 to $199 per month, that medication is coming from one of these facilities. It contains semaglutide, the active ingredient in Wegovy - not an FDA-approved product and not reviewed by the FDA for safety, effectiveness, or quality, but manufactured under federal outsourcing pharmacy oversight.

Phentermine is a Schedule IV controlled substance, and Illinois does not have the same telehealth prescribing restrictions on controlled substances that some other states have imposed. In practice, this means an Illinois-licensed telehealth physician can prescribe phentermine without requiring an in-person visit first, though individual platforms set their own policies. Ro, PlushCare, and Peter MD are among the Illinois-available options that include phentermine in their treatment toolkit. If phentermine is specifically what you want, confirm with the platform before completing your intake.

The clinical threshold that applies across all Illinois-serving providers is a BMI of 30 or higher without a comorbidity, or a BMI of 27 or higher with a qualifying condition like type 2 diabetes, hypertension, or high cholesterol. This is the FDA standard, and Illinois telehealth providers follow it. If you are close to 27 with a health condition, you very likely qualify. If you are below 27 with no comorbidities, most platforms will not prescribe GLP-1 medications to you.

If price is your primary concern and you are paying out of pocket, Medvi is the answer. Their compounded semaglutide program runs $149 to $199 per month all-inclusive, which means the consultation, medication, and ongoing provider access are bundled into that price. There are no separate visit fees, no prescription markup, and no subscription tiers to compare. Medvi has 33,200 verified reviews with an 8.9 rating, which means the low price is not coming at the cost of quality. They are the top pick on this list for a reason.

Skinny.Rx is the other budget-first option available in Illinois. They offer compounded semaglutide with straightforward monthly pricing and fewer add-ons. Their review count is significantly lower than Medvi's at 4,378, but their 8.5 rating holds up. If Medvi is sold out of a starting dose tier or has a waitlist, Skinny.Rx is a legitimate fallback. Both platforms are no-frills in the best sense: you are paying for medication and provider access, not coaching content you may not use.

For Illinois residents who are uninsured or underinsured and want something that includes more support, Shed offers compounded GLP-1 medications bundled with behavioral coaching. Their pricing sits above Medvi's but below the full-service platforms. MyStart Health is another option in this middle tier, with all-inclusive GLP-1 monthly pricing and lifestyle coaching, rated 8.6 from 21,600 reviews and currently positioned as the best option for people who are newer to GLP-1 treatment and want more guidance along the way.

Illinois has full telehealth parity, so your insurance company cannot reimburse an in-person weight loss visit at a higher rate than a telehealth one. That is a meaningful protection that not every state has. It does not, however, mean your insurance will automatically cover GLP-1 medications. Wegovy, Ozempic, and Zepbound coverage depends entirely on your specific plan, your employer, and whether your plan has added obesity treatment as a covered category.

Ro is the Illinois-available platform best positioned to help you work through this. They are rated 8.9 from 32,100 reviews and are specifically described as a clinical-grade platform with real insurance navigation for brand-name GLP-1s including Wegovy and Ozempic. If getting Wegovy covered by your plan is the goal, Ro has infrastructure to help you pursue prior authorization, appeal denials, and document clinical necessity. That is different from a platform that simply writes you a compounded semaglutide prescription and sends it to a 503B pharmacy.

Henry Meds is another Illinois-available option that works directly with insurance for Ozempic and other GLP-1s. Their specialty is diabetes and weight loss, which makes them well-suited for Illinois residents who have type 2 diabetes or prediabetes and may have better insurance coverage for Ozempic as a diabetes medication rather than a weight loss drug. Henry Meds has 12,600 reviews at an 8.6 rating. If your situation involves insulin resistance or a diabetes diagnosis alongside your weight loss goal, they are worth looking at specifically.

PlushCare is the only Illinois-available platform that functions as a full primary care telehealth service that takes insurance. Rated 8.6 from 19,200 reviews, they cover weight loss alongside general primary care, mental health, and ED. If you want one telehealth provider that can handle your weight loss prescription and a sick visit and a blood pressure follow-up, PlushCare's insurance-accepted model is a different kind of value than any of the weight loss specialty platforms can offer.

Both compounded semaglutide and compounded tirzepatide are available to Illinois residents through telehealth providers in 2026. Semaglutide is the active ingredient in Wegovy and Ozempic. Tirzepatide is the active ingredient in Zepbound and Mounjaro. The compounded versions are manufactured at 503B pharmacies and contain the same active molecule, but are not FDA-approved branded products. Illinois providers that offer both give you and your prescribing provider a choice based on your clinical history and cost tolerance.

Compounded tirzepatide tends to cost more than compounded semaglutide because tirzepatide is a newer dual-agonist medication with a different mechanism. Platforms like Sprout Health, Shed, and MyStart Health offer access to GLP-1 medications broadly, and their compounded options often include both semaglutide and tirzepatide depending on what your provider recommends. If you are comparing platforms and tirzepatide access matters to you, ask specifically before completing an intake form, because not every Illinois provider includes it at the same price tier.

Brand-name Wegovy and Zepbound are available in Illinois through platforms with insurance navigation capability, primarily Ro and Henry Meds. If your insurance covers Wegovy, you may pay a copay in the $25 to $100 range per month rather than the full retail price, which can exceed $1,300. If your insurance does not cover it and you are paying out of pocket, compounded semaglutide at $149 to $199 monthly through Medvi is a substantial cost difference that most Illinois residents paying cash will find hard to ignore.

If you are searching for the lowest monthly cost with compounded semaglutide and do not want to deal with insurance: Medvi at $149 to $199 per month is the clearest recommendation. It is rated near the top of all Illinois-available providers, has the largest review base among the budget options, and includes everything in the monthly price.

If you have commercial insurance and want to pursue brand-name Wegovy or Ozempic: Start with Ro. Their insurance navigation process is built for exactly this scenario, and they have the clinical infrastructure to help you document your case for coverage. If Ro's process does not work out with your insurer, Henry Meds is a strong alternative especially if your situation involves a diabetes-adjacent diagnosis.

If you are new to GLP-1 treatment and want coaching alongside your medication: MyStart Health is specifically positioned as the best option for beginners, and their all-inclusive pricing with lifestyle coaching reflects that. Sprout Health is another Illinois-available option with nutritionist support built into their plan. Both are rated above 8.5 and have meaningful review bases.

If you want a platform for weight loss plus other health concerns: Hims (9.0, 34,200 reviews) and Hers (8.8, 29,800 reviews) are the strongest multi-condition platforms available in Illinois. Hims covers weight loss, ED, hair loss, and mental health. Hers covers weight loss, birth control, hair loss, and mental health. If you are managing more than one health area and want a single telehealth relationship, either of those is a more practical choice than a weight loss specialist.

If you want the most flexibility without a subscription: Sesame Care operates a pay-per-visit marketplace model with transparent pricing and no monthly commitment. Rated 8.7 from 25,400 reviews, they are the right answer if you want a one-time consultation with an Illinois-licensed weight loss physician before deciding on a program, or if you dislike the idea of being locked into a monthly plan while you figure out how your body responds.

Illinois has a meaningful uninsured and underinsured population, and weight loss telehealth has genuinely expanded access for people who cannot afford in-person bariatric consultations or primary care. The cash-pay market for GLP-1 medications has become competitive enough that $149 per month for compounded semaglutide is now a real option, not a promotional teaser price. Medvi and Skinny.Rx operate at that level for Illinois residents without insurance.

The realistic monthly cost range for compounded semaglutide through Illinois telehealth providers runs from $149 at the low end with Medvi to roughly $300 to $350 at mid-tier platforms that include more coaching or clinical touchpoints. Compounded tirzepatide tends to run $100 to $200 higher per month than semaglutide through the same platforms, reflecting the higher cost of the raw compound.

One thing worth knowing if you are uninsured in Illinois: some providers charge a separate consultation fee at intake that is not included in the monthly subscription price. Medvi's all-inclusive pricing avoids this, but if you are evaluating a platform not explicitly described as all-inclusive, ask what the first-month total cost actually is before you hand over a credit card. The intake consultation fee at some platforms can add $50 to $100 to your first month.

For Illinois residents who have a lower income and are on Medicaid: the coverage picture is not good. Illinois Medicaid generally does not cover GLP-1 medications for weight loss, and the telehealth consultation parity that applies to commercial insurance does not extend to Medicaid in the same way for obesity treatment. This is a gap in coverage that affects a real number of Illinois residents, and the practical answer for now remains cash-pay at budget platforms.

Phentermine is one of the most searched weight loss medications in Illinois, and for good reason. It has decades of clinical history, it is far cheaper than GLP-1 medications, and it works meaningfully well for short-term appetite suppression. As a Schedule IV controlled substance, its telehealth prescribing has faced restrictions in some states. Illinois is not one of them. An Illinois-licensed physician can legally prescribe phentermine via telehealth without requiring a prior in-person visit, as long as they conduct a proper clinical evaluation through the telehealth encounter.

Not every platform that serves Illinois will prescribe phentermine, even though it is legal here. Some platforms are GLP-1 only by business design. If phentermine is specifically what you want because of its lower cost or because a previous doctor had you on it, look at Ro, PlushCare, and Peter MD among the Illinois-available options. Peter MD is a men's health and weight loss specialist that uses physician-led protocols and covers phentermine explicitly as part of its weight loss toolkit. PlushCare, as a primary care platform, has the broadest prescribing flexibility of any Illinois telehealth provider on this list.

Phentermine is typically prescribed for 12 weeks or less due to its stimulant classification and the risk of tolerance. Monthly cash prices for phentermine itself are low, often $15 to $40 for the medication through a pharmacy. The telehealth consultation to get the prescription is where the cost sits. Sesame Care's transparent per-visit pricing model may be the most cost-effective path for Illinois residents who want a single phentermine consultation without committing to a monthly subscription.

Every Illinois weight loss telehealth provider follows a similar intake process. You fill out a health history form that covers your BMI, existing conditions, current medications, and weight loss history. A licensed Illinois physician or nurse practitioner reviews your intake, sometimes asynchronously and sometimes through a video or phone visit. If you qualify clinically, a prescription is sent to a pharmacy, either one the platform works with or one of your choosing depending on the platform. Most Illinois residents report getting a response within 24 to 48 hours of submitting their intake.

The BMI threshold of 30 without a comorbidity or 27 with one is the standard gate. Come prepared with your height and weight, and know that platforms may ask you to confirm a comorbidity with documentation or simply attest to it. If you have been diagnosed with hypertension, sleep apnea, high cholesterol, or type 2 diabetes, that qualifies as a comorbidity and expands your eligibility.

If you are in Illinois and starting from zero, the most practical path for most people is: pick a platform based on whether you have insurance or are paying cash, complete the intake honestly, and start at whatever dosing your provider recommends. GLP-1 medications require titration over weeks to months, and you will not reach the full therapeutic dose immediately. The platforms that include coaching, like MyStart Health and Sprout Health, can be genuinely useful during that titration period when side effects like nausea are most common. If side effects are minimal and you just want the medication, a no-frills platform like Medvi or Skinny.Rx makes more financial sense for Illinois residents paying out of pocket.